IL50091A - 4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them - Google Patents

4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them

Info

Publication number
IL50091A
IL50091A IL50091A IL5009176A IL50091A IL 50091 A IL50091 A IL 50091A IL 50091 A IL50091 A IL 50091A IL 5009176 A IL5009176 A IL 5009176A IL 50091 A IL50091 A IL 50091A
Authority
IL
Israel
Prior art keywords
oxazolidinones
substituted
production
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL50091A
Other languages
English (en)
Other versions
IL50091A0 (en
Original Assignee
Nordmark Werke Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordmark Werke Gmbh filed Critical Nordmark Werke Gmbh
Publication of IL50091A0 publication Critical patent/IL50091A0/xx
Publication of IL50091A publication Critical patent/IL50091A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL50091A 1975-08-29 1976-07-21 4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them IL50091A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2538424A DE2538424C2 (de) 1975-08-29 1975-08-29 4-substituierte 5-Phenyl-oxazolidon-(2)- Verbindungen und ein diese enthaltendes pharmazeutisches Präparat

Publications (2)

Publication Number Publication Date
IL50091A0 IL50091A0 (en) 1976-09-30
IL50091A true IL50091A (en) 1981-01-30

Family

ID=5955093

Family Applications (1)

Application Number Title Priority Date Filing Date
IL50091A IL50091A (en) 1975-08-29 1976-07-21 4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them

Country Status (22)

Country Link
US (1) US4139538A (sv)
JP (1) JPS5253857A (sv)
AT (1) AT347453B (sv)
AU (1) AU506441B2 (sv)
BE (1) BE845581A (sv)
CA (1) CA1072567A (sv)
CH (1) CH623043A5 (sv)
DE (1) DE2538424C2 (sv)
DK (1) DK387876A (sv)
FI (1) FI62074C (sv)
FR (1) FR2321884A1 (sv)
GB (1) GB1555658A (sv)
HU (1) HU174488B (sv)
IE (1) IE43396B1 (sv)
IL (1) IL50091A (sv)
IN (1) IN144061B (sv)
LU (1) LU75659A1 (sv)
NL (1) NL7609559A (sv)
NO (1) NO143316C (sv)
PL (1) PL100901B1 (sv)
SE (1) SE424991B (sv)
ZA (1) ZA764279B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179442A (en) * 1975-08-29 1979-12-18 York Hartleben 4-(Alpha-hydroxy-isopropyl)-5-phenyl-oxazolidin-2-one
LU80081A1 (fr) * 1977-08-26 1979-05-15 Delalande Sa Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
DE2961251D1 (en) * 1978-08-15 1982-01-14 Smithkline Beckman Corp A method of preparing a 2-hydroxy-3-isopropyl or a 2-hydroxy-3-tert-butylaminopropyl aromatic ether
US5105009A (en) * 1983-06-02 1992-04-14 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
US5623087A (en) * 1995-03-10 1997-04-22 Ndsu-Research Foundation Method for preparation of optically active diarylalanines
GB9826700D0 (en) * 1998-12-05 1999-01-27 Univ Durham Process for preparing chiral compounds
WO2001074792A2 (en) * 2000-03-31 2001-10-11 Abbott Laboratories Process for the preparation of matrix metalloproteinase inhibitors
US20020019539A1 (en) 2000-03-31 2002-02-14 Bailey Anne E. Process for the preparation of matrix metalloproteinase inhibitors
FR2832613B1 (fr) * 2001-11-27 2004-02-13 Seb Sa Panier de cuisson d'aliments pour autocuiseur, autocuiseur destne a recevoir un panier de cuisson et procede de fabrication d'un panier de cuisson d'aliments par emboutissage
WO2008032191A2 (en) 2006-09-13 2008-03-20 Astrazeneca Ab Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
WO2014067861A1 (en) * 2012-10-29 2014-05-08 F. Hoffmann-La Roche Ag 3,4-disubstituted oxazolidinone derivatives and their use as inhibitors of the calcium activated potassium channel

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1302662B (sv) * 1971-02-04
US2399118A (en) * 1942-02-13 1946-04-23 Mallinckrodt Chemical Works 2-oxazolidone compounds and method for preparing the same
DE1157627B (de) * 1957-08-28 1963-11-21 Robins Co Inc A H Verfahren zur Herstellung von 5-(o-Alkoxyphenoxymethyl)-oxazolidonen-(2)
DE1130131B (de) * 1957-11-08 1962-05-24 Eugen Bellmann G M B H Maschf Bundkippzange
BE585502A (fr) 1958-12-09 1960-06-09 American Cyanamid Co Composes hétérocycliques azotés et procéde pour leur préparation.
US3133932A (en) * 1959-05-25 1964-05-19 Deere & Co Production of 2-oxazolidinones
DE1198368B (de) * 1959-08-06 1965-08-12 Robins Co Inc A H Verfahren zur Herstellung von 5-(2, 6-Dimethoxyphenoxymethyl)-oxazolidon-(2)
DE1803180U (de) * 1959-11-05 1959-12-31 Wickmann Werke Ag Freiluft-isolator.
FR1274416A (fr) * 1959-12-09 1961-10-27 American Cyanamid Co Procédé de préparation de nouvelles aryloxyméthyl-2-oxazolidinones
US3450674A (en) * 1963-10-04 1969-06-17 Dow Chemical Co Poly-n-heterocyclics and method
GB1102011A (en) * 1964-05-21 1968-02-07 Richardson Merrell Spa Phenol esters of amino acids
NL129025C (sv) * 1965-04-29
US3538064A (en) * 1965-06-04 1970-11-03 Commercial Solvents Corp Acrylic acid esters of hydroxymethyl oxazolidones
GB1224995A (en) * 1968-09-20 1971-03-10 Delalande Sa New 5-propargyloxymethyl-2-substituted oxazolidinones and their process of preparation
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
ZA71932B (en) * 1970-02-27 1971-10-27 Ici Ltd Organic compounds
BE763964A (fr) * 1970-03-24 1971-09-08 Delalande Sa Nouveaux derives de l'aminocarbonyl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique
FR2179582B1 (sv) * 1972-04-13 1975-10-10 Synthelabo

Also Published As

Publication number Publication date
HU174488B (hu) 1980-01-28
JPS5253857A (en) 1977-04-30
CA1072567A (en) 1980-02-26
FR2321884A1 (fr) 1977-03-25
SE424991B (sv) 1982-08-23
AU506441B2 (en) 1980-01-03
IN144061B (sv) 1978-03-18
FR2321884B1 (sv) 1979-03-23
AT347453B (de) 1978-12-27
DK387876A (da) 1977-03-01
IE43396L (en) 1977-02-28
PL100901B1 (pl) 1978-11-30
US4139538A (en) 1979-02-13
JPS564554B2 (sv) 1981-01-30
IL50091A0 (en) 1976-09-30
AU1614576A (en) 1978-01-26
CH623043A5 (sv) 1981-05-15
BE845581A (fr) 1976-12-16
ZA764279B (en) 1977-07-27
NO143316C (no) 1981-01-14
LU75659A1 (sv) 1977-03-31
IE43396B1 (en) 1981-02-11
FI62074B (fi) 1982-07-30
NO143316B (no) 1980-10-06
FI62074C (fi) 1982-11-10
NO762928L (sv) 1977-03-01
DE2538424C2 (de) 1983-01-05
GB1555658A (en) 1979-11-14
ATA619876A (de) 1978-05-15
DE2538424A1 (de) 1977-03-03
SE7609426L (sv) 1977-03-01
NL7609559A (nl) 1977-03-02
FI762400A (sv) 1977-03-01

Similar Documents

Publication Publication Date Title
IL50836A0 (en) Novel cyclopolypeptides their production and pharmaceutical compositions containing them
IL49238A (en) O-aminoethyl trifluoromethyl-phenyl-ketoximes, their preparation and pharmaceutical compositions containing them
IL49022A0 (en) Isoxazolylbenzamide derivatives,their production and pharmaceutical compositions containing them
IL46760A (en) 2-tetrahydrofurfuryl-6,7-benzomorphane derivatives,their production and pharmaceutical compositions containing them
IL55382A (en) Propenylamines,their production and pharmaceutical compositions containing them
IL47877A0 (en) Novel thienothiazine derivatives,their manufacture and pharmaceutical compositions containing them
IL50631A0 (en) 1-benzazolylalkyl-4-substituted-piperidines,their preparation and pharmaceutical compositions containing them
IL49788A0 (en) 11-desoxy-16-aryloxy-omega-pentanorprostaglandins,their preparation and pharmaceutical compositions containing them
IL47735A (en) 8a-substituted-6-alkyl-ergoline i derivatives,their production and pharmaceutical compositions containing them
IL50091A (en) 4-substituted-2-oxazolidinones,their production and pharmaceutical compositions containing them
IL49180A0 (en) New polypeptides,their production and pharmaceutical compositions containing them
IL50542A (en) Substituted pyridinecarboxamides,their manufacture and pharmaceutical compositions containing them
IL53332A (en) 3-fluoro-6-piperazino-morphanthridine derivatives,their production and pharmaceutical compositions containing them
IL55207A0 (en) Novel benzodiazepine-diones,their production and pharmaceutical compositions containing them
IL50797A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
IL54105A0 (en) Novel benzylpyrimidines, their production and pharmaceutical compositions containing them
IL49862A0 (en) New benzocycloheptathiophene derivatives,their production and pharmaceutical compositions containing them
IL46593A0 (en) New 2-amino-6-dialkylaminodihydropyridines,their production and pharmaceutical compositions containing them
IL49099A (en) Xanthene-9-carboxylates, their preparation and pharmaceutical compositions containing them
IL48788A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
IL49785A0 (en) Benzocycloheptathiophene derivatives,their production and pharmaceutical compositions containing them
IL49277A0 (en) New isoquinoline derivatives,their production and pharmaceutical compositions containing them
IL49847A0 (en) New penicillins,their preparation and pharmaceutical compositions containing them
IL51104A (en) 4a-phenyl-isoquinoline derivatives,their production and pharmaceutical compositions containing them
IL49124A0 (en) Novel d-homosteroids,their manufacture and pharmaceutical compositions containing them